Sat.Aug 10, 2024 - Fri.Aug 16, 2024

article thumbnail

Considering the use of animal models in drug development

Drug Discovery World

Professor Andy Whiting , CEO of Nevrargenics, asks whether animal models should be used as the default regulatory requirement and explores the times to use them. Animal models (AMs) have generally been seen as useful for drug development and biomedical research for many years. They are assumed to closely mimic human disease progression and act as a good testing ground for toxicology studies and pharmacokinetics 1.

article thumbnail

Scientists achieve more than 98% efficiency removing nanoplastics from water

Science Daily: Pharmacology News

Linked to cardiovascular and respiratory diseases in people, nanoplastics continue to build up, largely unnoticed, in the world's bodies of water. The challenge remains to develop a cost-effective solution to get rid of nanoplastics while leaving clean water behind. That's where Mizzou comes in. Recently, researchers created a new liquid-based solution that eliminates more than 98% of these microscopic plastic particles from water.

Disease 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Baicalein Enhances Radiosensitivity in Colorectal Cancer via JAK2/STAT3 Pathway Inhibition

Chemical Biology and Drug Design

Baicalein (BE) augments radiosensitivity in colorectal cancer (CRC) by inhibiting the JAK2/STAT3 pathway. In vitro and in vivo experiments demonstrate BE's ability to enhance apoptosis and suppress PD-L1 expression, suggesting its potential as a radiosensitizer in CRC therapy. ABSTRACT Radiation resistance is a crucial factor influencing therapeutic outcomes in colorectal cancer (CRC).

Therapies 100
article thumbnail

FDA Authorizes First At-Home Test for Syphilis

Drugs.com

FRIDAY, Aug. 16, 2024 -- As syphilis cases surge throughout the United States, the U.S. Food and Drug Administration on Friday approved the first diagnostic at-home test to spot the bacterial disease."This is the first at-home, over-the-counter.

FDA 119
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Partners use generative AI to develop novel cancer therapeutics

Drug Discovery World

The Memorial Sloan Kettering Cancer Center (MSK) will be collaborating with Absci Corporation to discover and develop novel cancer therapeutics using generative artificial intelligence (AI) for up to six programmes. Under the terms of the collaboration, Absci and MSK’s cancer research teams will co-develop therapeutics using Absci’s platform. “At MSK, we are committed to continuous innovation as we strive toward our mission of ending cancer for life, and we expect cancer care AI to play an incre

article thumbnail

New brain-computer interface allows man with ALS to 'speak' again

Science Daily: Pharmacology News

A new brain-computer interface translates brain signals into speech with up to 97 percent accuracy. Researchers implanted sensors in the brain of a man with severely impaired speech due to amyotrophic lateral sclerosis (ALS). The man was able to communicate his intended speech within minutes of activating the system.

Research 143

More Trending

article thumbnail

Medicare reveals results of drug price negotiations

BioPharma Drive: Drug Pricing

The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.

Drugs 120
article thumbnail

Genetic causes of colorectal cancer revealed in new study

Drug Discovery World

A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to treatment. The research was led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds.

Treatment 162
article thumbnail

Cleaning up the aging brain: Scientists restore brain's trash disposal system

Science Daily: Pharmacology News

Scientists have restored the brain's waste-clearing process in aging mice, offering potential new treatment for Alzheimer's and Parkinson's using existing drugs.

Treatment 145
article thumbnail

FDA Says No to MDMA as Therapy for PTSD

Drugs.com

MONDAY, Aug. 12, 2024 -- Advocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S. Food and Drug Administration declined to approve it as treatment for.

Therapies 115
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Pfizer, BioNTech stumble in effort to develop combination flu, COVID shot

BioPharma Drive: Drug Pricing

The vaccine didn’t spur a strong enough immune response against a particular flu strain in a Phase 3 trial, leading the companies to ponder adjustments.

article thumbnail

This week in drug discovery (12-16 August) 

Drug Discovery World

News round-up for 12-16 August by DDW Senior Digital Content Editor Diana Spencer. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic approaches to cancer treatment. The top stories: Genetic causes of colorectal cancer revealed in new study A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to trea

Licensing 147
article thumbnail

Brain wiring is guided by activity even in very early development

Science Daily: Pharmacology News

In humans, the process of learning is driven by different groups of cells in the brain firing together. For instance, when the neurons associated with the process of recognizing a dog begin to fire in a coordinated manner in response to the cells that encode the features of a dog -- four legs, fur, a tail, etc. -- a young child will eventually be able to identify dogs going forward.

139
139
article thumbnail

Red Meat Could Be Prime Driver of Colon Cancer in the Young

Drugs.com

FRIDAY, Aug. 16, 2024 -- There are clues that red and processed meats could be driving the increased risk of colon cancer in young adults, a new study claims.Younger colon cancer patients typically have higher levels of metabolites created by the.

111
111
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Following FDA rejection, a journal retracts papers on MDMA-assisted therapy

BioPharma Drive: Drug Pricing

Editors at Psychopharmacology cited "unethical conduct" that the study authors didn't disclose when submitting the papers. Lykos Therapeutics says it filed a complaint with a third party to review the way the journal came to its decision.

Therapies 113
article thumbnail

New data support antitumour drug misetionamide in ovarian cancers

Drug Discovery World

New published data have demonstrated positive monotherapy results for misetionamide as well as synergistic activity with PARP inhibitors (PARPis) and bevacizumab antineoplastic in ovarian cancer. Misetionamide is a tumour cell selective small molecule drug that is broadly active in multiple cancer models. Misetionamide’s inhibition of hexokinase-2 (HK-2), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and pyruvate dehydrogenase (PVD) in aerobic glycolysis inhibits ATP production for cancer ce

article thumbnail

Engineers design tiny batteries for powering cell-sized robots

Science Daily: Pharmacology News

A zinc-air microbattery could enable the deployment of cell-sized, autonomous robots for drug delivery within in the human body, as well as other applications such as locating leaks in gas pipelines.

article thumbnail

Looking for Symptoms to Catch Ovarian Cancer Early

Drugs.com

THURSDAY, Aug. 15, 2024 -- Ovarian cancer is known as a "silent killer," since by the time symptoms arise the disease has often already spread.But in certain cases of aggressive ovarian cancer, symptoms do arise in the tumor's early stages. In.

Disease 110
article thumbnail

Lykos to cut 75% of staff after FDA rejection of MDMA-based therapy

BioPharma Drive: Drug Pricing

The layoffs are part of a larger reorganization that will also see the departure of Lykos’ founder, the psychedelics advocate Rick Doblin.

Therapies 120
article thumbnail

‘100 Million Cell Challenge’ to boost single cell genomics research

Drug Discovery World

Scale Biosciences (Scale Bio) has launched the ‘100 Million Cell Challenge’, which hopes to push the boundaries of single-cell genomics research, in collaboration with Ultima Genomics and NVIDIA. The programme calls on researchers worldwide to submit proposals for large-scale single cell projects, with the goal of collectively analysing 100 million cells or more across diverse biological systems and research areas.

Research 147
article thumbnail

Rethinking the dodo

Science Daily: Pharmacology News

Researchers are setting out to challenge our misconceptions about the Dodo, one of the most well-known but poorly understood species of bird. Researchers have undertaken the most comprehensive review of the taxonomy of the Dodo and its closest relative, the Rodriguez Island Solitaire.

Research 135
article thumbnail

Women in STEM with Charlotte Owens

Drug Target Review

Can you tell us about your journey in the field of STEM and the challenges you encountered along the way? I grew up in California where I developed a natural curiosity to understand how a living organism functions. Majoring in physiology in college allowed me to nourish this interest, and I knew medicine would be my path as it enabled me to learn the structure and function of the human body.

article thumbnail

Your Brain Cells 'Reset' During Sleep, Readying for Tomorrow's Memories

Drugs.com

FRIDAY, Aug. 16, 2024 -- A good night’s sleep is crucial for helping people make new memories, a new study says.Neurons that capture new memories during the day reset while you sleep, researchers reported Aug. 15 in the journal Science.“This mec.

Science 105
article thumbnail

AI drug discovery research consortium welcomes six new members

Drug Discovery World

OpenFold, a non-profit artificial intelligence (AI) research consortium focused on developing free and open-source software tools for biology and drug discovery, has added six new industry members. Joining the consortium are Astex Pharmaceuticals, Biogen, Congruence Therapeutics, Polaris Quantum Biotech, Psivant Therapeutics, and SandboxAQ. “This expansion marks a significant stride forward in advancing AI-driven solutions for healthcare and life sciences,” said Christina Taylor, Senior Science

Research 147
article thumbnail

Smart fabric converts body heat into electricity

Science Daily: Pharmacology News

Researchers have developed a smart fabric that can convert body heat and solar energy into electricity, potentially enabling continuous operation with no need for an external power source. Different sensors monitoring temperature, stress, and more can be integrated into the material.

Research 134
article thumbnail

The Marina Orth Foundation and The Last Mile Education Fund Receive Perficient Global Grant

Perficient: Drug Development

At Perficient, we take immense pride in igniting positive change around the world. Since Perficient’s Giving Employee Resource Group (ERG) launching the Perficient Global Grants Program earlier this year, we have seen remarkable enthusiasm and commitment from our global colleagues, each championing their favorite charitable causes with passion and purpose.

article thumbnail

Sweden Reports First Case of New Mpox Strain as Africa Outbreak Continues

Drugs.com

FRIDAY, Aug. 16, 2024 -- As an outbreak of a new strain of mpox continues in Africa, Sweden announced Thursday that it has confirmed the first case in that country.Known as the clade I strain, this latest iteration of mpox appears to be spread.

105
105
article thumbnail

‘Molecular switch’ could reverse the effects of alopecia

Drug Discovery World

A Phase IIa clinical trial has begun evaluating the safety and efficacy of Pelage Pharmaceuticals’ PP405, a novel topical small molecule, for the treatment of androgenetic alopecia (pattern baldness). The company is enrolling 60 women and men for the clinical study. PP405 is designed to reactivate dormant hair follicle stem cells to stimulate hair growth.

article thumbnail

It's a rave: Underground acoustics amplify soil health

Science Daily: Pharmacology News

Barely audible to human ears, healthy soils produce a cacophony of sounds in many forms -- a bit like an underground rave concert of bubble pops and clicks. Special recordings made by ecologists show this chaotic mixture of soundscapes can be a measure of the diversity of tiny living animals in the soil, which create sounds as they move and interact with their environment.

130
130
article thumbnail

CDD Vault Integrates Enamine Compound Collection into AI-Powered Structural Similarity Searches

Collaborative Drug

Burlingame, CA (USA), Kyiv (Ukraine) – August 16, 2024 — Collaborative Drug Discovery (CDD), a leader in providing scientific informatics solutions, announced today that its flagship platform, CDD Vault , now includes the complete compound collection of Enamine , a leading provider of chemical compounds and early discovery services, within its AI module for structural similarity searches.

Research 103
article thumbnail

Text Message Program Helps Teens at Risk for Suicide

Drugs.com

FRIDAY, Aug. 16, 2024 -- Kids considering suicide after receiving mental health care at a hospital can be helped by automated text messages that help them feel hopeful and supported, a new study finds.Children receiving the texts as part of a.

Hospitals 105
article thumbnail

Lynparza and Imfinzi combination approved in the EU for endometrial cancer

Drug Discovery World

AstraZeneca’s Imfinzi (durvalumab) and Lynparza (olaparib) have been approved in the European Union (EU) as treatment for certain patients with primary advanced or recurrent endometrial cancer. Imfinzi plus chemotherapy as first-line treatment followed by Lynparza and Imfinzi has been approved for patients with mismatch repair proficient (pMMR) disease.

Trials 147
article thumbnail

Engineers make tunable, shape-changing metamaterial inspired by vintage toys

Science Daily: Pharmacology News

Common push puppet toys in the shapes of animals and popular figures can move or collapse with the push of a button at the bottom of the toys' base. Now, a team of engineers has created a new class of tunable dynamic material that mimics the inner workings of push puppets, with applications for soft robotics, reconfigurable architectures and space engineering.

article thumbnail

FDA approves Ascendis drug for rare endocrine condition

BioPharma Drive: Drug Pricing

The clearance of Yorvipath for hypoparathyroidism was some time coming for Ascendis, which had resubmitted after receiving a rejection last year.